SCHEMBL8630868

SCHEMBL8630868

NC(=O)N(O)C(=O)CC[C@H](N)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ GSR P00390 2/20 0.54
▸ CYP1A2 P05177 2/20 0.54
▸ GRM8 O00222 1/20 0.54
▸ GRM6 O15303 1/20 0.54
▸ GRIN2D O15399 1/20 0.54
▸ GRIN3B O60391 1/20 0.54
▸ GRIK1 P39086 1/20 0.54
▸ GRM5 P41594 1/20 0.54
▸ GRIA1 P42261 1/20 0.54
▸ GRIA2 P42262 1/20 0.54
▸ GRIA3 P42263 1/20 0.54
▸ SLC1A3 P43003 1/20 0.54
▸ SLC1A2 P43004 1/20 0.54
▸ SLC1A1 P43005 1/20 0.54
▸ GRIA4 P48058 1/20 0.54
▸ GRIN1 Q05586 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22598251 0.78 GLO1 (0.58) ALOX15BLMPMP22KMT2AGSR
SCHEMBL11712204 0.75 GSR (0.58) ALOX15BLMPMP22KMT2AGSR
SCHEMBL197385 0.75 GSR (0.58) ALOX15BLMPMP22KMT2AGSR
SCHEMBL1768449 0.75 GSR (0.58) ALOX15BLMPMP22KMT2AGSR
SCHEMBL3381963 0.75 GSR (0.58) ALOX15BLMPMP22KMT2AGSR
SCHEMBL3382365 0.73 GSR (0.56) ALOX15BLMPMP22KMT2AGSR
Glutamine SCHEMBL411575 0.73 KMT2A (1.00) ALOX15BLMPMP22KMT2AGSR
Glutamine SCHEMBL7453 0.73 KMT2A (1.00) ALOX15BLMPMP22KMT2AGSR
Glutamine SCHEMBL7452 0.73 KMT2A (1.00) ALOX15BLMPMP22KMT2AGSR
Glutamine SCHEMBL411588 0.73 KMT2A (1.00) ALOX15BLMPMP22KMT2AGSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5854006-A Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof THE UNIVERSITY OF VIRGINIA (US) 1998-12-29 — — US disclosed
Send feedback